Introduction {#section1-0022034519883673}
============

Orofacial clefts and orofacial trauma are clinical conditions that involve impaired orofacial muscle regeneration as well as fibrosis. Orofacial clefts are common birth defects that often include cleft palate and/or a cleft in the soft palate in about 46% of the cases ([@bibr2-0022034519883673]; [@bibr60-0022034519883673]). These disorders occur in 1:500 to 1:2,500 births and are surgically treated in the first or second year after birth. Prior to reconstructive surgery, these children show impaired speech development and swallowing. After surgery, speech problems persist in about 30% of the patients, which may lead to social and psychological problems. This is mainly caused by incomplete muscle regeneration and fibrosis ([@bibr10-0022034519883673]).

The orofacial muscles include the muscles of mastication, the muscles of cheeks and lips, the soft palate muscles, the suprahyoid muscles, and the tongue muscles ([@bibr33-0022034519883673]). These muscles develop from the mesoderm of the pharyngeal arches and the occipital somites ([@bibr53-0022034519883673]; [@bibr11-0022034519883673]). The muscles of the trunk and limbs develop from the thoracic and lumbal somites, respectively ([@bibr11-0022034519883673]). The molecular pathways that regulate orofacial muscle development differ from those in trunk and limb muscles ([@bibr11-0022034519883673]). Embryonic myogenesis in skeletal muscles involves the differentiation of mesodermal cells into myogenic cells. These cells migrate to their specific body region and differentiate into myoblasts, proliferate, and fuse into myofibers ([@bibr6-0022034519883673]). Another population of precursor cells will later become the quiescent satellite cells (SCs) in the adult muscle that provide muscle growth and regeneration after injury, although their origin is still controversial ([@bibr44-0022034519883673]). Upon injury, regulatory pathways are activated that also function during muscle development ([@bibr26-0022034519883673]).

The functions of human orofacial muscles include chewing, swallowing, and speech. Chewing is carried out by movements of the lower jaw ([@bibr33-0022034519883673]) while swallowing requires the coordinated action of the tongue, soft palate, and the suprahyoid muscles ([@bibr33-0022034519883673]; [@bibr23-0022034519883673]). Speech is coordinated by contractions of the orofacial muscles and the larynx ([@bibr23-0022034519883673]). The functioning of muscle fibers is determined by specific myosin heavy-chain (MyHC) isoforms ([@bibr50-0022034519883673]). During development, myofibers express embryonic MyHC, which is gradually replaced by other isoforms ([@bibr50-0022034519883673]). The exact regulation of expression of specific MyHC isoforms is still unclear.

In addition to the developmental differences, orofacial muscles seem to regenerate less and develop more fibrosis after injury than limb and trunk muscles ([@bibr46-0022034519883673]; [@bibr7-0022034519883673]; [@bibr12-0022034519883673]). Thus, specific approaches are required to improve orofacial muscle regeneration after surgical reconstruction. Here we discuss orofacial muscle development and regeneration to identify specific targets to improve the treatment of orofacial muscle defects.

Orofacial Muscle Development {#section2-0022034519883673}
============================

The orofacial muscles comprise the muscles of the lower face and the oral cavity. Their development takes place in 2 different regions of the embryo head ([@bibr11-0022034519883673]). The mesoderm of the pharyngeal arches gives rise to the branchiomeric muscles that include the masticatory muscles, the buccinators, the orbicularis oris muscles, the muscles of the soft palate, and the suprahyoid muscles ([Fig. 1](#fig1-0022034519883673){ref-type="fig"}). The occipital somites give rise to the muscles of the tongue ([Fig. 1D](#fig1-0022034519883673){ref-type="fig"}) ([@bibr38-0022034519883673]; [@bibr11-0022034519883673]; [@bibr51-0022034519883673]). Studies in chicks, rodents, and zebrafish show that cranial neural crest cells (CNCCs) in the embryo head direct muscle development and differentiate into the intramuscular connective tissue ([@bibr57-0022034519883673]; [@bibr19-0022034519883673]; [@bibr37-0022034519883673]). In zebrafish and other vertebrates, retinoic acid (RA) maintains the nondifferentiated state of precursor cells during proliferation ([@bibr15-0022034519883673]; [@bibr37-0022034519883673]). Subsequently, the degradation of RA allows the precursor cells to form myofibers and tendons ([@bibr37-0022034519883673]). The main regulatory factors and pathways are discussed in the next sections.

![The orofacial muscles. (**A**) Schematic of the skull. 1. Temporalis. 2. Masseter. 3. Buccinator. 4. Orbicularis oris. (**B**) Sagittal view of the head. N, nose; M, mandible; U, upper jaw. 5. Lateral pterygoid. 6. Medial pterygoid. (**C**) Upper jaw and soft palate. SP, soft palate. 7. Tensor veli palatini. 8. Levator veli palatini. 9. Musculus uvulae. 10. Palatoglossus. 11. Palatopharyngeous. (**D**) Muscles of the tongue. Hy, hyoid bone. 12. Styloglossus. (**D**) 13. Superior longitudinalis. 14. Transverse muscle. 15. Vertical muscle. 16. Inferior longitudinalis. 17. Genioglossus. 18. Hyoglossus. (**E**) Suprahyoid muscles. Hy, hyoid bone. 19. Mylohyoid. 20. Geniohyoid. 21. Stylohyoid. 22. Digastricus (anterior and posterior belly).](10.1177_0022034519883673-fig1){#fig1-0022034519883673}

Molecular Regulation of Branchiomeric Muscle Development {#section3-0022034519883673}
--------------------------------------------------------

### Cranial Neural Crest Cells and Myogenic Commitment {#section4-0022034519883673}

The branchiomeric muscles ([Fig. 1](#fig1-0022034519883673){ref-type="fig"}) develop from the first, second, and fourth pharyngeal arches ([@bibr11-0022034519883673]). The third pharyngeal arch gives rise to the stylopharyngeous muscle, which is not considered an orofacial muscle ([@bibr16-0022034519883673]). In the developing neural tube, embryonic cells in the margins of the neural folds undergo epithelial-mesenchymal transition (EMT) and form the neural crest ([@bibr49-0022034519883673]; [@bibr54-0022034519883673]). Cells along the neural crest delaminate and migrate toward the different regions in the embryo ([@bibr49-0022034519883673]; [@bibr54-0022034519883673]). Some CNCCs migrate to the pharyngeal arches, where they form the intramuscular connective tissue and regulate orofacial muscle development ([@bibr19-0022034519883673]; [@bibr49-0022034519883673]). Their migration is stimulated by autocrine growth factors such as stromal-derived growth factor (SDF) and vascular endothelial growth factor (VEGF) ([@bibr49-0022034519883673]). SDF and VEGF are also produced during muscle regeneration after injury, which requires the migration of myoblasts ([@bibr59-0022034519883673]).

In the pharyngeal arches of zebrafish, the proliferation of CNCCs is regulated by platelet-derived growth factors and Talin 1, which connects the cytoplasmic tails of integrins to the actin cytoskeleton via vinculin ([@bibr36-0022034519883673]; [@bibr30-0022034519883673]). After proliferation, the CNCCs induce the concentration of mesodermal cells in the core of the pharyngeal arches ([Fig. 2](#fig2-0022034519883673){ref-type="fig"}). In mouse embryos, both mesodermal cells and CNCCs express paired-like homeodomain transcription factor 2 (*Pitx2*) ([@bibr52-0022034519883673]). *Pitx2* knockout mouse embryos show reduced proliferation of both cell types, smaller muscles, and reduced expression of T-box transcription factor 1 (*Tbx1*) in mesodermal cells and CNCCs ([@bibr52-0022034519883673]; [@bibr24-0022034519883673]). In vitro, C2C12 cells overexpressing *Pitx2* express increased levels of *Tbx1* ([@bibr52-0022034519883673]). These data indicate that PITX2 induces TBX1 to regulate the proliferation and concentration of mesodermal cells in the core of the pharyngeal arches surrounded by CNCCs ([@bibr19-0022034519883673]; [@bibr32-0022034519883673]). Interestingly, *Tbx1* knockout mouse embryos lack the core mesodermal cells ([@bibr19-0022034519883673]; [@bibr32-0022034519883673]).

![Branchiomeric muscle development. Cranial neural crest cells (CNCCs, pink) migrate toward the first, second, and fourth (1, 2, 4) pharyngeal arches (purple). Pitx2 stimulates *Tbx1* expression in CNCCs and mesodermal cells (brown color). The mesodermal cells concentrate in the core of the pharyngeal arches and become surrounded by CNCCs (step 1). Noggin (Nog), Gr (gremlin), and Frzb secreted by CNCCs prevent the downregulation of *Pax7* and *MyoD* by Bmp and Wnt. Fgf10 produced by CNCCs expressing *Dlx5* stimulates the expression of *Mrfs*. The CNCCs finally express *Scx* and differentiate into the intramuscular connective tissue and the tendons, while the mesodermal cells differentiate into myofibers (steps 2 and 3). Notch expressed by proliferating myoblasts limits their differentiation into myofibers.](10.1177_0022034519883673-fig2){#fig2-0022034519883673}

The CNCCs then differentiate into connective tissue precursors, while the mesodermal cells commit to the myogenic lineage ([Fig. 2](#fig2-0022034519883673){ref-type="fig"}). *Tbx1* knockout mouse embryos show reduced expressions of transcription factors such as scleraxis (SCX) in the CNCCs and capsulin (TCF21), myogenic repressor (MYOR), and myogenic factor 5 (MYF5) in the mesodermal cells ([@bibr52-0022034519883673]; [@bibr20-0022034519883673]; [@bibr19-0022034519883673]; [@bibr39-0022034519883673]; [@bibr32-0022034519883673]). In these embryos, tendon and muscle formation is impaired. *Tcf21* and *MyoR* double-knockout mouse embryos show reduced MYF5 expression in the core mesoderm and impaired muscle formation ([@bibr39-0022034519883673]). Thus, the connective tissue precursor cells express *Scx* while committed myogenic cells express *Myf5*. SCX-positive precursors proliferate and invade the mesodermal core to induce the differentiation of the committed cells into myoblasts. In *Tbx1* knockout mouse embryos, both the expression of *Scx* by precursor cells and the number of myoblasts are reduced ([@bibr20-0022034519883673]; [@bibr19-0022034519883673]; [@bibr32-0022034519883673]). This also indicates that TBX1 is crucial for myogenesis in the branchiomeric muscles. To summarize, CNCCs induce the concentration of mesodermal cells in the core of the pharyngeal arches. CNCCs then differentiate into SCX-positive precursors and the mesodermal cells commit to myogenesis. Subsequently, the SCX-positive cells induce the early differentiation of the committed cells into myoblasts. This is a crucial interaction between the neuroectoderm and the mesoderm during orofacial myogenesis.

### Myofiber Formation {#section5-0022034519883673}

The final steps in branchiomeric muscle formation are the differentiation of myoblasts into myofibers and the formation of the intramuscular connective tissue and the tendons ([Fig. 2](#fig2-0022034519883673){ref-type="fig"}). In chick embryos, SCX-positive precursors also express bone morphogenic protein 4 and 7 (*BMP4* and *BMP7*), *WNT1, WNT3a*, noggin, gremlin, and frizzled-related protein 3 (*FRZB*) during proliferation ([@bibr57-0022034519883673]). In vitro, BMP and WNT inhibit the proliferation and differentiation of myoblasts, which can be rescued by the addition of noggin, gremlin, or FRZB ([@bibr57-0022034519883673]). Simultaneously, *Dlx5* is expressed by SCX-positive precursors ([@bibr53-0022034519883673]). *Dlx5* knockout mouse embryos in this study show reduced fibroblast growth factor 10 (FGF10) expression and impaired branchiomeric muscle formation. In cultured myogenic cells from these knockouts, myofiber formation is rescued by FGF10 ([@bibr53-0022034519883673]). This suggests that FGF10 produced by SCX-positive precursors regulates the differentiation of myofibers by inducing myogenic regulatory factors (MRFs; see Table). In zebrafish, Scx-positive precursor cells express cytochrome P450-26B1 (*cyp26b1*), which degrades RA and thus promotes the differentiation of *Scx*-positive precursors in the pharyngeal arches ([@bibr37-0022034519883673]). The precursors differentiate to form the tendons and the intramuscular connective tissue ([@bibr37-0022034519883673]). This indicates a neuroectodermal origin of the muscular connective tissue in branchiomeric muscles. This aspect will be discussed in the regeneration section of this review.

###### 

Key Factors Involved in Orofacial Muscle Development and the Development of Trunk and Limb Muscles.

![](10.1177_0022034519883673-table1)

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                        Function in Orofacial Muscles                                         Function in Trunk and Limb Muscles                        References
  ------------------------------------------------------------------------------------- --------------------------------------------------------------------- --------------------------------------------------------- ------------------------------------------------------------------------------------
  **Transcription factors**                                                                                                                                                                                             

   Pitx2                                                                                Myoblast proliferation\                                               ↑ MyoD and Myf5\                                          [@bibr52-0022034519883673]
                                                                                        Myogenic differentiation\                                             Myogenic differentiation                                  
                                                                                        ↑ Tbx1 and MyoR                                                                                                                 

   Tbx1                                                                                 Myogenesis first and second arches\                                   No known function                                         [@bibr57-0022034519883673]; [@bibr20-0022034519883673]; [@bibr32-0022034519883673]
                                                                                        ↑ Myf-5, MyoD, FGF10                                                                                                            

   Msc (MyoR), Tcf21 (capsulin)                                                         Myogenesis of the first arch\                                         No known function                                         [@bibr52-0022034519883673]; [@bibr32-0022034519883673]
                                                                                        ↑ Tbx1, Myf-5, MyoD                                                                                                             

   Pax3                                                                                 ↑ Migration and tongue muscle development                             ↑ Induce myogenic pathways                                [@bibr5-0022034519883673]; [@bibr42-0022034519883673]

   Dlx5                                                                                 ↑ Myogenesis                                                          Not essential for myogenesis                              [@bibr53-0022034519883673]

   Scx                                                                                  Tendon development                                                    Neural crest cells induce Scx-positive precursor cells\   [@bibr5-0022034519883673]; [@bibr42-0022034519883673]
                                                                                                                                                              Tendon development                                        

   Six1, Six4                                                                           No known function                                                     ↑ Pax3                                                    [@bibr5-0022034519883673]; [@bibr11-0022034519883673]

   Mrfs (Myf5, Pax7, MyoD, MyoG)                                                        ↑ Proliferation and differentiation                                   Idem                                                      

  **Growth factor signaling** ^[a](#table-fn1-0022034519883673){ref-type="table-fn"}^                                                                                                                                   

   Noggin, gremlin, Frzb                                                                ↓ Wnt, Shh, Bmp\                                                      ↓ Myogenesis                                              [@bibr21-0022034519883673]; [@bibr11-0022034519883673]
                                                                                        ↑ Myogenesis                                                                                                                    

   Shh, Wnt1, Wnt3, Wnt3a, Bmp4, Bmp7, Tgfβ1                                            ↓ Myogenesis in branchiomeric muscles\                                ↑ Myogenesis\                                             [@bibr21-0022034519883673]; [@bibr11-0022034519883673]
                                                                                        ↑ Tongue myogenesis\                                                  ↑ Mrfs\                                                   
                                                                                        ↓ Muscle regeneration                                                 Tgfβ1 ↓ muscle regeneration                               

   Fgf1, Fgf2, Fgf5, Fgf6                                                               ↑ Mrfs in the tongue bud                                              ↓ Myogenesis during development\                          [@bibr11-0022034519883673]; [@bibr47-0022034519883673]
                                                                                                                                                              ↑ Muscle regeneration                                     

   Fgf10                                                                                Interaction between cranial neural crest cells and mesodermal cells   Somitogenesis\                                            [@bibr53-0022034519883673]
                                                                                                                                                              Outgrowth of the limb buds                                

   Notch                                                                                ↓ MyoD (myogenic differentiation)\                                    Idem                                                      [@bibr13-0022034519883673]
                                                                                        Maintains the pool of satellite cells postnatally                                                                               
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Growth factor signaling includes growth factors, receptors, and inhibitors.

During myofiber formation, the MYF5-positive myoblasts express paired homeobox factor 7 (*Pax7*) and myogenic differentiation factor (*MyoD*) ([@bibr20-0022034519883673]; [@bibr39-0022034519883673]). *Myf5* and *MyoD* double-knockout embryos lack differentiated branchiomeric muscles ([@bibr31-0022034519883673]). Normally, MYOD-positive cells start to express myogenin (*MyoG*), fuse, and form myofibers ([@bibr26-0022034519883673]; [@bibr11-0022034519883673]) ([Fig. 2](#fig2-0022034519883673){ref-type="fig"}). Myoblasts also express *Notch* during myofiber formation, while *Notch* knockout embryos show small or absent branchiomeric muscles ([@bibr13-0022034519883673]). In vitro, PAX7- and MYOD-positive myoblasts overexpressing *Notch* do not form myotubes but remain in the proliferation phase ([@bibr40-0022034519883673]). Within myofibers, satellite cells (SCs) reside between the sarcolemma and the basal lamina in a quiescent state ([@bibr40-0022034519883673]; [@bibr13-0022034519883673]). In vivo and in vitro studies show that NOTCH maintains the pool of SCs throughout life ([@bibr40-0022034519883673]; [@bibr13-0022034519883673]). As in trunk and limb muscles, the SCs can regenerate orofacial muscle tissue, which will be discussed later.

Molecular Regulation of Tongue Muscle Development {#section6-0022034519883673}
-------------------------------------------------

### Occipital Somites, Cell Migration, and Myogenic Commitment {#section7-0022034519883673}

The development of the tongue muscles occurs in the occipital somites and the mesoderm of the tongue bud ([Fig. 3](#fig3-0022034519883673){ref-type="fig"}). Mesodermal cells commit to myogenesis in the occipital somites, which is induced by CNCCs ([Fig. 3--1](#fig3-0022034519883673){ref-type="fig"}). These CNCCs have migrated from the neural crest region toward the occipital somites ([@bibr43-0022034519883673]; [@bibr54-0022034519883673]). There, the early myogenic differentiation of mesodermal cells occurs. Cultured somites of chick embryo heads express *MRFs* in the mesodermal cells upon addition of sonic hedgehog (SHH), WNT1, or WNT3 ([@bibr41-0022034519883673]; [@bibr43-0022034519883673]). In the occipital somites of mouse embryos, *Bmp4, Wnt3a*, and *Shh* are expressed by CNCCs, while *Mrfs* are expressed by the mesodermal cells ([@bibr57-0022034519883673]). The factors that stimulate the expression of these proteins are not known.

![Tongue muscle development. Cranial neural crest cells (CNCCs; pink) and mesodermal cells (brown) regulate tongue myogenesis in the first pharyngeal arch (PA). CNCCs migrate directly from the neural crest to the first pharyngeal arch but also to the occipital somites (OSs). In the OSs, the CNCCs induce the commitment of mesodermal cells to the myogenic lineage by expressing Shh-Wnt. The committed cells migrate (brown arrow) toward the first pharyngeal arch (steps 1 and 2). The CNCCs in the tongue bud start to express *Scx* and will form the intramuscular connective tissue and the tendons. These Scx-positive precursors secrete TGFB1 and BMP to induce the differentiation of the committed cells. The committed cells then differentiate into myoblasts under control of MRFs and form the myofibers (step 3). Notch expressed by proliferating myoblasts controls their differentiation into myofibers. This figure is available in color online.](10.1177_0022034519883673-fig3){#fig3-0022034519883673}

After commitment, the myogenic cells from the occipital somites migrate toward the forming tongue and differentiate into myoblasts ([Fig. 3--2](#fig3-0022034519883673){ref-type="fig"}). Chick embryo studies indicate that PAX3- and PAX7-positive myogenic cells migrate along the hypoglossal nerve ([@bibr29-0022034519883673]; [@bibr6-0022034519883673]). The tongue bud is growing by the proliferation of mesodermal cells and the invading CNCCs in the midline of the first pharyngeal arch ([@bibr21-0022034519883673]; [@bibr14-0022034519883673]; [@bibr54-0022034519883673]). In the developing tongue bud of mouse embryos, CNCCs start to express *Scx* and turn into connective tissue precursors ([@bibr21-0022034519883673]). *Scx* expression by CNCC-derived precursors is induced by transforming growth factor β1 (TGFβ1) and WNT1, as shown in studies on double-knockout mouse embryos ([@bibr28-0022034519883673]). These embryos exhibit microglossia and disorganized myofibers. *Wnt3a, Fgf1, Fgf2, Fgf5*, and *Fgf6* are expressed in the tongue mesoderm of mouse embryos and seem to induce *Myf5, Pax7*, and *MyoD* ([@bibr21-0022034519883673]; [@bibr14-0022034519883673]). However, *Myf5* knockout mouse embryos show reduced levels of FGF6 and an atrophic tongue ([@bibr22-0022034519883673]). In vitro, myogenesis in the tongue bud of these knockouts can be rescued by FGF6 ([@bibr22-0022034519883673]). These data indicate that FGFs induce myogenesis in the forming tongue, while there seems to be a positive feedback by MRFs.

### Myofiber Formation {#section8-0022034519883673}

Finally, myofibers and connective tissue are formed in the tongue bud ([Fig. 3--3](#fig3-0022034519883673){ref-type="fig"}). Organ cultures of mouse embryo tongues show that *Mrf* expression and myofiber formation require BMP- and SMAD-dependent *Tgfb1* expression by SCX-positive precursors ([@bibr22-0022034519883673]). *Myf5-Smad* double-knockout mouse embryos show continued myoblast proliferation, reduced *Myog* expression, and low myofiber formation, leading to an atrophic tongue. In wild-type tongue buds, SCX-positive precursors surround the myogenic cells and induce their differentiation ([@bibr22-0022034519883673]). As in branchiomeric muscles, NOTCH represses myofiber formation and maintains the pool of postnatal SCs ([@bibr13-0022034519883673]). Also, the connective tissue induces the differentiation of myogenic cells into myoblasts. Later, the association between the myofibers and the connective tissue allows complex tongue movements in speaking and deglutition. The interaction between the neuroectodermal connective tissue and the pharyngeal mesoderm is also crucial during tongue myogenesis. Similar interactions might influence muscle regeneration after injury. This will be discussed in the next sections of this review.

Genetic Factors in Orofacial Clefts and Muscle Development {#section9-0022034519883673}
----------------------------------------------------------

Orofacial clefts (OFCs) are classified into syndromic and nonsyndromic cases. The nonsyndromic cases represent about 70% of all OFC cases ([@bibr4-0022034519883673]; [@bibr1-0022034519883673]). Genes such as *PAX7, GRHL3, FGF, FGFR2, IRF6, BMP4, TGFA, TGFB1*, and *VAX1* are reported as causal genes for OFC ([@bibr4-0022034519883673]; [@bibr35-0022034519883673]; [@bibr1-0022034519883673]). Of these genes, *PAX7, BMP4, FGF2*, and *FGF5* are also related to muscle development. In vertebrates, *PAX7* is involved in the regulation of CNCC migration, and at later stages, it is also expressed by myogenic cells and myoblasts ([@bibr34-0022034519883673]; [@bibr6-0022034519883673]). Postnatally, PAX7 in SCs regulates muscle regeneration after injury ([@bibr34-0022034519883673]; [@bibr6-0022034519883673]). In mouse embryos, BMP4 induces the proliferation of myogenic cells during tongue, lip, and soft palate development but not their differentiation ([@bibr21-0022034519883673]; [@bibr34-0022034519883673]; [@bibr48-0022034519883673]). In contrast, FGF2 and FGF5 only stimulate the differentiation of myogenic cells into myoblasts and their fusion into myofibers ([@bibr22-0022034519883673]; [@bibr35-0022034519883673]). Although there is no direct evidence, these genes might be related to impaired muscle development and regeneration in OFC patients.

Differences with Trunk and Limb Muscles during Development {#section10-0022034519883673}
----------------------------------------------------------

In trunk and limb muscles, the regulation of myogenesis is quite different. Several excellent reviews discuss this in detail, but we will give a short overview here ([@bibr5-0022034519883673]; [@bibr38-0022034519883673]; [@bibr27-0022034519883673]; [@bibr42-0022034519883673]; [@bibr11-0022034519883673]; [@bibr51-0022034519883673]). In the thoracic and lumbal somites, the committed myogenic cells migrate under the control of WNT1, WNT3, WNT7a, and sonic hedgehog (SHH) expressed in the notochord and the neural tube ([@bibr11-0022034519883673]). In contrast to the branchiomeric muscles, FRZB, gremlin, and noggin do not seem to play a role in myogenesis. In trunk and limbs, the mesoderm differentiates into the tendons and the intramuscular connective tissue while the migrated committed cells differentiate into myoblasts ([@bibr42-0022034519883673]). In trunk and limb myogenesis, SIX1 and SIX4 induce PAX3, which stimulates the expression of MRFs by myoblasts ([@bibr5-0022034519883673]). The MRFs induce the proliferation and differentiation of myoblasts into myofibers. PAX3 also stimulates the expression of PITX2, which induces PAX7 and MYOD to regulate myofiber formation ([@bibr5-0022034519883673]; [@bibr27-0022034519883673]). Thus, orofacial myogenesis differs from that in other skeletal muscles by the molecular interactions between CNCCs and mesodermal cells.

The Origins of Satellite Cells {#section11-0022034519883673}
------------------------------

In the branchiomeric muscles of chick embryos, SCs are present in the core of the pharyngeal arches together with myogenic cells ([@bibr25-0022034519883673]). The SCs remain quiescent during myofiber formation. This suggests that branchiomeric SCs and myogenic cells share a common mesodermal origin. In mouse embryos, SCs are also present in the occipital somites ([@bibr25-0022034519883673]). These SCs migrate to the first pharyngeal arch together with myogenic cells ([@bibr25-0022034519883673]). In trunk and limb muscles, mesodermal cells in the somites give rise to both the myogenic cells and the SCs ([@bibr3-0022034519883673]; [@bibr62-0022034519883673]). Both cell types migrate toward specific body regions where the myogenic cells differentiate into myofibers ([@bibr3-0022034519883673]; [@bibr62-0022034519883673]). The SCs reside at the outer side of the myofibers ([Fig. 4](#fig4-0022034519883673){ref-type="fig"}). Alternative origins of SCs in the somites and the developing muscles are endothelial cells and neural crest cells (NCCs) ([@bibr3-0022034519883673]; [@bibr62-0022034519883673]). Intriguingly, SCs from orofacial muscles have a mesodermal origin, while SCs from trunk and limb muscles can have a mesodermal or an ectodermal origin ([@bibr25-0022034519883673]). In contrast, the connective tissue in orofacial muscles originates from the ectoderm, while in trunk and limb muscles, it originates from the mesoderm ([@bibr3-0022034519883673]; [@bibr62-0022034519883673]). This suggests that the difference in behavior of SCs in terms of proliferation and differentiation is related to their origin. Similarly, this might explain the differences in regeneration and fibrosis between these muscle groups. In the next section, the regeneration of orofacial muscles is discussed.

![Promoting orofacial muscle regeneration. Enhancement of satellite cell (SC) differentiation is key to improve the regeneration of orofacial muscles. Growth factors that can stimulate SC differentiation are fibroblast growth factor (FGF), hepatocyte growth factor (HGF), insulin-like growth factor (IGF), vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and stromal cell--derived factor (SDF). Targeting transforming growth factor β1 (TGFβ1) is the main strategy to reduce fibrosis. Aligned scaffolds (gray lines) are required to deliver growth factors and antifibrotic factors into the wound site and to guide myofiber orientation.](10.1177_0022034519883673-fig4){#fig4-0022034519883673}

Orofacial Muscle Regeneration {#section12-0022034519883673}
=============================

In all skeletal muscles, regeneration starts with inflammation followed by tissue formation and remodeling, which may end up in fibrosis ([@bibr18-0022034519883673]). Injury disrupts the connection between the muscle fibers and the adjacent connective tissue, thereby activating the SCs ([@bibr56-0022034519883673]). SCs are the stem cells of muscle tissue and mainly responsible for its regenerative capacity. Proliferating SCs express *PAX7* and differentiate into myoblasts that start to express *MYOD* and then fuse to form MYOG-positive myotubes maturing into myofibers. The activity of SCs largely depends on their microenvironment or niche ([@bibr18-0022034519883673]; [@bibr55-0022034519883673]; [@bibr26-0022034519883673]) ([Fig. 4](#fig4-0022034519883673){ref-type="fig"}). Their activation takes place by growth factors such as FGF6, vascular endothelial growth factor (VEGF), and hepatocyte growth factor (HGF) ([@bibr55-0022034519883673]). FGF1 and FGF2 secreted by SCs after injury stimulate their own proliferation and the expression of MRFs ([@bibr47-0022034519883673]). In addition, both SCs and invading macrophages secrete matrix metalloproteinases (MMP2 and MMP9) to degrade extracellular matrix (ECM) components. Fibroblasts differentiate into myofibroblasts stimulated by TGFβ1 to deposit ECM components, mainly collagen I. TGFβ1 is the main factor inducing fibrosis and reducing SC proliferation and myofiber formation in all adult muscles ([@bibr62-0022034519883673]; [@bibr61-0022034519883673]). As discussed earlier, during tongue development, TGFβ1 promotes myofiber formation ([@bibr22-0022034519883673]). Clearly, the role of TGFβ1 is different in muscle development and in the adult muscle.

In mice, freeze injuries of the masseter muscle regenerate less effectively than similar injuries of the tibialis anterior muscle ([@bibr46-0022034519883673]). This was shown by a lower number of regenerated myofibers of smaller diameter. Moreover, much more fibrous tissue was formed. In a model for muscle regeneration in the rat, a circular full-thickness wound was made in the soft palate ([@bibr8-0022034519883673]; [@bibr7-0022034519883673]). Large numbers of myofibroblasts were detected in the wound area around 7 d after wounding. Histology also showed a 3-fold increase in collagen content at 56 d, while only few myofibers had regenerated. In vitro, SCs from the masseter muscle of mice show a higher proliferation rate and a delayed differentiation compared with SCs from the extensor digitorum longus muscle ([@bibr44-0022034519883673]). This was also shown for SCs from other orofacial muscles, including the soft palate muscles in rats ([@bibr7-0022034519883673]; [@bibr9-0022034519883673]). Interestingly, when transplanted, mouse masseter-derived SCs regenerated limb muscles as efficiently as those from the EDL itself ([@bibr44-0022034519883673]). These data indicate that orofacial muscles regenerate less than limb and trunk muscles and develop more fibrosis. Other adult connective tissues derived from the ectoderm such as that in skin and heart also show extensive fibrosis after injury ([@bibr45-0022034519883673]). It appears that ectoderm-derived fibroblasts respond more strongly to TGFβ1, readily differentiate into myofibroblasts, and produce ECM components at a higher rate. Therefore, the ectodermal origin of the connective tissue in orofacial muscles might explain why these muscles develop more fibrosis and regenerate less than other skeletal muscles.

Promoting Orofacial Muscle Regeneration {#section13-0022034519883673}
---------------------------------------

Strategies to promote orofacial muscle regeneration should target both the low differentiation ability of the SCs and the strong tendency for fibrosis. Previous work on trunk and limb muscles indicates that SC differentiation is enhanced by growth factors such as FGF1, FGF2, and FGF6 ([@bibr56-0022034519883673]; [@bibr47-0022034519883673]). Other factors that stimulate muscle regeneration in trunk and limbs are HGF, insulin-like growth factor (IGF), VEGF, platelet-derived growth factor (PDGF), and stromal cell--derived factor (SDF) ([@bibr18-0022034519883673]; [@bibr55-0022034519883673]; [@bibr59-0022034519883673]). These factors are present in the ECM of skeletal muscles and regulate the proliferation and differentiation of SCs ([@bibr18-0022034519883673], [@bibr55-0022034519883673]). These growth factors might be used to improve the regenerative ability of orofacial SCs. Strategies to promote regeneration in trunk and limb muscles include the inhibition of fibrosis with microRNAs (miRNAs), decorin, and small molecules such as losartan that target the TGFβ1/myofibroblast axis ([@bibr17-0022034519883673]; [@bibr58-0022034519883673]; [@bibr59-0022034519883673]). As discussed earlier, the proliferation and differentiation of ectoderm-derived fibroblasts into myofibroblasts are strongly stimulated by TGFβ1. The implantation of SCs or nonmyogenic stem cells in the site of the injury might not be the best approach since they generally do not survive for long in vivo ([@bibr59-0022034519883673]). A more efficient strategy might be the delivery of growth factors and antifibrotic components to the impaired tissue in scaffolds or hydrogels. This might also be more cost-effective for future clinical applications.

Future strategies to promote orofacial muscle regeneration should target the specific aspects of orofacial muscle development and regeneration. Local SCs and other stem cells with myogenic potential may be stimulated by applying growth factors such as FGFs and HGF. Simultaneously, the TGFβ1/myofibroblasts axis should be targeted by using small-molecule inhibitors or miRNAs to prevent fibrosis. This may enhance orofacial muscle regeneration and the treatment of orofacial muscle defects.

Conclusion {#section14-0022034519883673}
==========

Orofacial muscle development is regulated by CNCCs that will eventually form the intramuscular connective tissue and the tendons. Thus, the connective tissue of orofacial muscles is of ectodermal origin. In contrast, the development of trunk and limb muscles is induced by the notochord in the thoracic and lumbar somites. In contrast to the CNCCs, the NCCs in trunk and limb muscle development do not differentiate into the intramuscular connective tissue. Instead, the connective tissue is of mesodermal origin. In general, connective tissue of ectodermal origin has a strong tendency for fibrosis after injury. Similarly, the ectodermal origin of the connective tissue in orofacial muscles might increase fibrosis. In addition, SCs from orofacial muscles have a lower differentiation capacity compared to those from trunk and limb muscles. Thus, the improvement of orofacial muscle regeneration should therefore focus on both the stimulation of SC differentiation and the reduction of fibrosis. Therapeutic strategies to improve the regeneration of orofacial muscles (e.g., after surgery in orofacial clefting) should include antifibrotic agents as well as growth factors that stimulate satellite cell differentiation such as FGFs and HGF. These approaches may greatly improve the outcome of orofacial cleft surgery and reconstructive surgery after tumor resection or trauma in the orofacial region.
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